Trial record 1 of 1 for:    01461915
Previous Study | Return to List | Next Study

Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane (PGPC1)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Cantex Pharmaceuticals.
Recruitment status was  Recruiting
Translational Drug Development
Information provided by (Responsible Party):
Cantex Pharmaceuticals Identifier:
First received: October 13, 2011
Last updated: November 9, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)